• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG COBAS® LIAT® SARS-COV-2 & INFLUENZA A/B; COVID-19 MULTI-ANALYTE RESPIRATORY PANEL NUCLEIC ACID DEVICES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG COBAS® LIAT® SARS-COV-2 & INFLUENZA A/B; COVID-19 MULTI-ANALYTE RESPIRATORY PANEL NUCLEIC ACID DEVICES Back to Search Results
Catalog Number 09211101190
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); Output Problem (3005); Non Reproducible Results (4029)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/12/2021
Event Type  malfunction  
Manufacturer Narrative
Investigation is ongoing.A follow-up report will be filed upon the completion of the investigation.(b)(4).
 
Event Description
In light of the covid-19 pandemic and the subsequent emergency use authorizations (euas) for sars-cov-2 diagnostic tests, the agency has requested heightened reporting beyond the reasonably suggests requirements of 803 to include allegations of false positive or false negative results independent of harm or malfunction or off-label use.Pursuant to the agency¿s instruction, we hereby submit this mdr.The customer alleged discrepant results generated for the cobas® sars-cov-2 & influenza a/b (scfa) assay.A customer from the united states alleged that they received a potential false positive result for a patient¿s sample tested with the cobas® sars-cov-2 & influenza a/b (scfa) assay.The customer reported that on (b)(6) 2021 they observed a sars-cov-2 negative, influenza a negative, influenza b positive result for a patient¿s sample tested and analyzed on the cobas® liat® system (s/n14341).The patient¿s same sample was repeat tested on a different platform the cepheid that generated a sars-cov-2 negative, influenza a negative, influenza b negative result.Patient sample was collected using nasopharyngeal swab in remel universal transport media.The customer confirmed there was no allegation of harm to the patient.The negative result was reported out to the patient and/or personnel treating the patient.The investigation to assess the customer allegation has not yet been completed.
 
Manufacturer Narrative
Instrument data was not provided from the liat for review of instrument performance and it cannot be determined if these samples may have been near the limit of detection (lod) for the influenza b on the scfa assay.The influenza b lod differs significantly between the cobas® sars-cov-2 & influenza a/b test on the cobas® liat system and the cepheid which could explain the sample discrepancies.The lod for cepheid is claimed at 0.19 (victoria) - 0.4 (yamagata) tcid/50ml (depending on the strain).The scfa package insert indicates that the cobas® liat system influenza b lod is 0.002 (brisbabe and florida) - 0.004 (malaysia) tcid/50ml (depending on the strain), which indicates a much more sensitive test versus the cepheid.In addition, the influenza b strains detected can vary from one platform to another.As such, results with one assay may not be reproducible with a different assay.The customer states they believe the issue was due to an expired lot in use that is now discarded.They request the investigation be closed.Although requested, no further information was provided on the lot in use at the time of the allegation.Customer claims they used an expired assay kit.Differences in testing platforms could also contribute to the discrepancy.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS® LIAT® SARS-COV-2 & INFLUENZA A/B
Type of Device
COVID-19 MULTI-ANALYTE RESPIRATORY PANEL NUCLEIC ACID DEVICES
Manufacturer (Section D)
ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG
1080 us highway 202 south
branchburg NJ 08876
Manufacturer (Section G)
ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG
1080 us highway 202 south
na
branchburg NJ 08876
Manufacturer Contact
stacie-ann creighton
1080 us hwy 202 s
na
branchburg, NJ 08876
9082537112
MDR Report Key13026524
MDR Text Key287813850
Report Number2243471-2021-03862
Device Sequence Number1
Product Code QLT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EUA201779
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/18/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/17/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2021
Device Catalogue Number09211101190
Device Lot Number01214U
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/22/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? Yes
Patient Sequence Number1
Patient Age62 YR
Patient SexFemale
-
-